These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

687 related articles for article (PubMed ID: 23110540)

  • 1. Toward the development of decision supporting tools that can be used for safe production and use of nanomaterials.
    Som C; Nowack B; Krug HF; Wick P
    Acc Chem Res; 2013 Mar; 46(3):863-72. PubMed ID: 23110540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In silico analysis of nanomaterials hazard and risk.
    Cohen Y; Rallo R; Liu R; Liu HH
    Acc Chem Res; 2013 Mar; 46(3):802-12. PubMed ID: 23138971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk management frameworks for human health and environmental risks.
    Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S
    J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The carcinogenic potential of nanomaterials, their release from products and options for regulating them.
    Becker H; Herzberg F; Schulte A; Kolossa-Gehring M
    Int J Hyg Environ Health; 2011 Jun; 214(3):231-8. PubMed ID: 21168363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology.
    Oberdörster G
    J Intern Med; 2010 Jan; 267(1):89-105. PubMed ID: 20059646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fate and risks of nanomaterials in aquatic and terrestrial environments.
    Batley GE; Kirby JK; McLaughlin MJ
    Acc Chem Res; 2013 Mar; 46(3):854-62. PubMed ID: 22759090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Moving toward exposure and risk evaluation of nanomaterials: challenges and future directions.
    Thomas T; Bahadori T; Savage N; Thomas K
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2009; 1(4):426-33. PubMed ID: 20049808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The importance of life cycle concepts for the development of safe nanoproducts.
    Som C; Berges M; Chaudhry Q; Dusinska M; Fernandes TF; Olsen SI; Nowack B
    Toxicology; 2010 Mar; 269(2-3):160-9. PubMed ID: 20025922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ecological nanotoxicology: integrating nanomaterial hazard considerations across the subcellular, population, community, and ecosystems levels.
    Holden PA; Nisbet RM; Lenihan HS; Miller RJ; Cherr GN; Schimel JP; Gardea-Torresdey JL
    Acc Chem Res; 2013 Mar; 46(3):813-22. PubMed ID: 23039211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanotechnology: the next big thing, or much ado about nothing?
    Maynard AD
    Ann Occup Hyg; 2007 Jan; 51(1):1-12. PubMed ID: 17041243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The hierarchy of environmental health and safety practices in the U.S. nanotechnology workplace.
    Engeman CD; Baumgartner L; Carr BM; Fish AM; Meyerhofer JD; Satterfield TA; Holden PA; Harthorn BH
    J Occup Environ Hyg; 2013; 10(9):487-95. PubMed ID: 23927041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Environmental benefits and risks of zero-valent iron nanoparticles (nZVI) for in situ remediation: risk mitigation or trade-off?
    Grieger KD; Fjordbøge A; Hartmann NB; Eriksson E; Bjerg PL; Baun A
    J Contam Hydrol; 2010 Nov; 118(3-4):165-83. PubMed ID: 20813426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guidance for handling and use of nanomaterials at the workplace.
    Heinemann M; Schäfer HG
    Hum Exp Toxicol; 2009 Jun; 28(6-7):407-11. PubMed ID: 19755453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A risk assessment framework for assessing metallic nanomaterials of environmental concern: aquatic exposure and behavior.
    O'Brien NJ; Cummins EJ
    Risk Anal; 2011 May; 31(5):706-26. PubMed ID: 21155861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Manufactured nanomaterials: categorization and approaches to hazard assessment.
    Gebel T; Foth H; Damm G; Freyberger A; Kramer PJ; Lilienblum W; Röhl C; Schupp T; Weiss C; Wollin KM; Hengstler JG
    Arch Toxicol; 2014 Dec; 88(12):2191-211. PubMed ID: 25326817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling approaches for characterizing and evaluating environmental exposure to engineered nanomaterials in support of risk-based decision making.
    Hendren CO; Lowry M; Grieger KD; Money ES; Johnston JM; Wiesner MR; Beaulieu SM
    Environ Sci Technol; 2013 Feb; 47(3):1190-205. PubMed ID: 23293982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantum dot cytotoxicity and ways to reduce it.
    Winnik FM; Maysinger D
    Acc Chem Res; 2013 Mar; 46(3):672-80. PubMed ID: 22775328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of an informatics-based decision-making framework and process to the assessment of radiation safety in nanotechnology.
    Hoover MD; Myers DS; Cash LJ; Guilmette RA; Kreyling WG; Oberdörster G; Smith R; Cassata JR; Boecker BB; Grissom MP
    Health Phys; 2015 Feb; 108(2):179-94. PubMed ID: 25551501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk assessment of engineered nanomaterials: a review of available data and approaches from a regulatory perspective.
    Hristozov DR; Gottardo S; Critto A; Marcomini A
    Nanotoxicology; 2012 Dec; 6():880-98. PubMed ID: 22229953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.